Delivery Order SPE2DB20D3101-SPE2DB24FQVX4
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $3,675.82 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 4560743507 - EPINEPHRINE 0.3 MG AUTO-INJECT 2S medical products. The contract has a period of performance through April 28, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which serves as the primary vehicle for the...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a Delivery Order valued at $11,098.25 for the supply of Epinephrine 0.3 mg Auto-Injector. This Firm Fixed Price contract has a completion date of July 1, 2024 and was awarded on June 28, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corporation's Corporate Office division to provide 4,564,803,699 units of Epinephrine 0.3 mg auto-injectors. The $3,900.60 firm fixed-price contract has a completion date of June 5, 2024 and is not set aside for any small business program. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to deliver a wide...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Epinephrine 0.3 mg auto-injectors. The $2,259.46 firm fixed-price contract has a completion date of June 23, 2022. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,495.30 firm fixed-price delivery order is for the supply of Epinephrine 0.3 mg auto-injectors. The contract has an ultimate completion date of April 29, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide EPINEPHRINE 0.3 MG AUTO-INJECT 2S. The contract has a potential value of $3,588.72 and a performance period through March 1, 2024. Amerisourcebergen Drug Corp, as the prime contractor, is also the holder of a larger indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through...
- The Defense Logistics Agency (DLA) awarded a delivery order contract, valued at $6,591.78, to Amerisourcebergen Drug Corp, a pharmaceutical distribution company, for the supply of EPINEPHRINE 0.3 MG AUTO-INJECT 2S. This contract has a completion date of May 7, 2024. The contract was awarded on May 6, 2024 and is a firm fixed-price, open competition contract with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which holds a significant...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $2,143.03 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 0.3 mg epinephrine auto-injectors. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025. The IDC allows DLA to efficiently procure a wide range of pharmaceutical products and medical...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Epinephrine 0.3 mg auto-inject 2s medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The $6,199.29 delivery order contract has an ultimate completion date of February 6, 2024 and is a firm fixed-price contract type. The contract was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. This $5,326.05 firm fixed price contract is for the delivery of epinephrine auto-injectors. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB24FQVX4Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide Epinephrine 0.3 mg auto-inject medication. The $2,081.48 firm-fixed-price contract has a completion date of December 5, 2023 and was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also has a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These contracts demonstrate Amerisourcebergen's capacity to meet the diverse and critical pharmaceutical needs of multiple government agencies on a large scale.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 12/4/23 |